The Week Ahead: Fed...
Health Care: Drugs
Arrowhead Research Corporation (ARWR: NASDAQ)
$3.85 -0.08 | -2.04%
06/04/12 - 10:57 AM ET
Company Balance Sheet
| Sep 2011 | Sep 2010 | Sep 2009 | Sep 2008 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 7.51M | 6.85M | 2.02M | 10.09M |
| Receivables | 1.61M | 930.68K | 147.26K | 86.60K |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 0.00 | 114.83K | 0.00 | 0.00 |
| Total Current Assets | 9.86M | 8.13M | 2.48M | 10.56M |
| Property, Plant & Equipment, Gross | 365.80K | 1.32M | 1.55M | 2.84M |
| Accumulated Depreciation & Depletion | 340.36K | 1.18M | 1.03M | 1.60M |
| Property, Plant & Equipment, Net | 25.44K | 141.27K | 527.04K | 1.25M |
| Intangibles | 1.73M | 2.05M | 2.36M | 2.75M |
| Other Non-Current Assets | 4.27M | 2.03M | 2.33M | 2.70M |
| Total Non-Current Assets | 6.03M | 4.22M | 5.22M | 6.69M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 15.89M | 12.35M | 7.70M | 17.26M |
| Accounts Payable | 576.81K | 681.56K | 1.01M | 1.34M |
| Short Term Debt | 0.00 | 0.00 | 726.53K | 810.46K |
| Other Current Liabilities | 0.00 | 2.41M | 184.35K | 479.29K |
| Total Current Liabilities | 2.58M | 4.28M | 2.34M | 3.73M |
| Long Term Debt | 606.79K | 0.00 | 500.00K | 0.00 |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 135.66K | 0.00 | 0.00 | 500.00K |
| Minority Interest | -363.51K | -1.18M | -60.00 | -7.45M |
| Total Non-Current Liabilities | 515.51K | -967.41K | 500.00K | 1.23M |
| Total Liabilities | 3.10M | 3.31M | 2.84M | 4.95M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 12.79M | 9.05M | 4.86M | 12.30M |
| Common Par | 86.42K | 71.74K | 56.43K | 42.95K |
| Additional Paid In Capital | 127.48M | 119.72M | 110.07M | 97.76M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -113.87M | -110.74M | -104.97M | -85.50M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | -900.00K | 0.00 | -300.00K | 0.00 |
| Total Capitalization | 13.40M | 9.05M | 5.36M | 12.30M |
| Total Equity | 12.79M | 9.05M | 4.86M | 12.30M |
| Total Liabilities & Stock Equity | 15.89M | 12.35M | 7.70M | 17.26M |
| Total Common Shares Outstanding | 8.64M | 7.17M | 5.64M | 4.29M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 7.18M | 6.43M | 4.52M | 3.92M |
| Diluted Weighted Shares Outstanding | 7.83M | 6.43M | 4.52M | 3.92M |
| Number of Employees | 57 | 18 | 20 | 68 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with ARWR
- Portfolio NameUser Type
- UserKJP 2012 Carbon Flash Fund
- Contributor8 Penny Stocks Get Delistin...
- UserWilliam T Blanchard - Medical
- UserCaroline
- UserSimon $9000
- Usertreneehill's pennies
- Userpeaka22 Portfolio 1
- Userkevin sweeney Portfolio 1
- UserWORLD FREE
- Userkeyon communications
Latest ARWR Headlines from TheStreet
- Arrowhead Research's CEO Hosts Alvos Acquisition Conference Call (Transcript) 05.08.12 | 12:05 am
- 6 Stocks Hitting New 52-Week Highs 11.10.11 | 01:11 pm
- 8 Penny Stocks Get Delisting Warning 01.04.11 | 07:01 am
- Arrowhead Research CEO Discusses F4Q2010 Results  Earnings Call Transcript 12.22.10 | 09:12 pm
- Arrowhead Research Corp. F3Q10 (Qtr End 06/30/10) Earnings Call Transcript 08.12.10 | 06:08 pm
- Mediacom, Jones Soda: Midday Volume Plays 06.01.10 | 10:06 am
- Arrowhead Research, Verenium: Early Volume Plays 03.22.10 | 07:03 am
- Amicas, Limelight: Early Volume Plays 12.28.09 | 07:12 am
- Thursday's Small-Cap Winners & Losers 06.20.07 | 01:06 am
- Friday's ETF Winners & Losers 06.20.07 | 01:06 am
Press Releases for ARWR
- Arrowhead Presents Data On DPC System At TIDES 2012 - Business Wire 05.22.12 | 07:05 am
- Arrowhead Reports Fiscal 2012 Second Quarter Financial Results - Business Wire 05.08.12 | 04:05 pm
- Arrowhead Research Corporation Acquires Alvos Therapeutics And Proprietary Library Of Targeting Peptides - Business Wire 04.11.12 | 07:04 am
- Arrowhead Releases White Paper On Hepatitis B Virus And Potential RNAi Treatment - Business Wire 03.07.12 | 07:03 am
- Arrowhead Research Corporation And Axolabs GmbH Enter Into Strategic Alliance And Master Services Agreement For RNAi Therapeutics - Business Wire 03.05.12 | 07:03 am
- Arrowhead Announces Patent Issuance Covering SiRNA Inhibitors Of HIF-2α (EPAS1) - Business Wire 02.29.12 | 07:02 am
- Arrowhead Reports Fiscal 2012 First Quarter Financial Results - Business Wire 02.09.12 | 04:02 pm
- Arrowhead To Report Fiscal 2012 First Quarter Financial Results - Business Wire 02.02.12 | 07:02 am
- Alnylam And Arrowhead Form Collaboration And Licensing Agreement - Business Wire 01.05.12 | 08:01 am
- Arrowhead Announces FDA Clearance To Initiate AdipotideTM Phase I Clinical Trial - Business Wire 01.04.12 | 07:01 am
Partner Headlines for ARWR
- 4 Smaller Alternatives to Big Pharma Obesity Treatments - Benzinga 05.25.12 | 01:05 pm
- Tekmira: RNAi Company With Long Term Potential, Short Term Catalysts - Seeking Alpha 03.07.12 | 08:03 am
- Arrowhead Reports Q1 EPS of $(0.02) - Benzinga 02.10.11 | 04:02 pm
- UPDATE 1-Arrowhead co, Smith & Nephew to make cartilage product - Reuters 10.18.10 | 08:10 am
